NOVO!! Preços e lista em tempo real para opções dos EUA (OPRA) Clique aqui para conhecer
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Oncternal Therapeutics Inc (ONCT)

  7. Oncternal Therapeutics Inc (ONCT) Balanços

ONCT

Oncternal Therapeutics Inc
0,785
-0,03 (-3,68%)
Upgrade para Tempo Real

Oncternal Therapeutics Inc. (ONCT) Fundamentals
Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need. The Company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to ROR1 (Receptor-tyrosine kinase-like Orphan Receptor 1), and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins. The Company is also developing ONCT-808, a CAR-T (chimeric antigen receptor T-cells) product candidate that targets ROR1 and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers.
SHARE INFORMATION
Market CapUS$ 47.849.833
Shares Outstanding58.711.451
Float58.195.131
Percent Float99,12%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -0,84
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions159
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months661.262
Institutional Holdings Percent30,0%
Institutional Sold Previous 3 Months4.850.416
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months1.867.196
Insider Holdings Percent25,8
Insider Sold Previous 3 Months62.102
Insider Shares Owned14.845.600
TRADING INFO
52 Week HighUS$ 1,87
52 Week LowUS$ 0,60
52 Week High ChangeUS$ -43,01
21 Day Moving AverageUS$ 0,7967
21 Day Extended Moving AverageUS$ 0,8105
50 Day Moving AverageUS$ 0,9504
50 Day Extended Moving AverageUS$ 0,894591
200 Day Moving AverageUS$ 1,0268
200 Day Extended Moving AverageUS$ 1,1598
10 Day Average Volume327.789
20 Day Average Volume283.757
30 Day Average Volume258.227
50 Day Average Volume206.305
Alpha-0.032752
Beta1.4561
Standard Deviation0.283232
R20.076644
7 Day Price ChangeUS$ -0,0628
7 Day Percent Change-7,15%
21 Day Price ChangeUS$ -0,0711
21 Day Percent Change-8,02%
30 Day Price ChangeUS$ -0,0766
30 Day Percent Change-8,59%
Month to Date Price ChangeUS$ -0,0766
Month to Date Percent Change-8,59%
Quarter to Date Price ChangeUS$ -0,185
Quarter to Date Percent Change-18,5%
180 Day Price ChangeUS$ -0,0766
180 Day Percent Change-8,59%
200 Day Price ChangeUS$ -0,255
200 Day Percent Change-23,83%
Year to Date Price ChangeUS$ -0,185
Year to Date Percent Change-18,5%

Oncternal Therapeutics Inc. (ONCT) Key Ratios

PROFITABILITY
EBIT Margin-818,5%
EBITDA Margin-818,5%
Pre-Tax Profit Margin0,0%
Profit Margin Count0,0%
Gross Margin0,0%
Profit Margin TOT0,0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0,00
Revenue (3 Years)US$ 0,00
Revenue (5 Years)US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book0,70
Total Debt To Equity0,00
Int Coverage0,00
Current Ratio8,80
Leverage Ratio1,10
Quick Ratio8,30
Long Term Debt To Capital0,00
VALUATION MEASURES
PE Ratio4,60
Enterprise ValueUS$ -19.509.474
Price to Sales0,00
Price to Free Cash-1,20
PE High Last 5 Years-1,40
Price To Book0,70
Price To Cash Flow0,00
PE Low Last 5 Years-2,60
Price to Tangible Book0,70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0,00
Invoice Turnover0,00
Assets Turnover0,00
Return Assets-54,45
Return on Equity-59,25
Return on Capital-50,36

Oncternal Therapeutics Inc. (ONCT) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorBDO USA, LLP
CEOJames B. Breitmeyer
Emplyoees30
Last AuditUE
CIK0001260990
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address12230 El Camino Real
Suite 230
San Diego, CA 92130
Websitehttps://www.oncternal.com
Facsimile+1 858 408-3010
Telephone+1 858 434-1113
Emailrvincent@oncternal.com
Seu Histórico Recente
NASDAQ
ONCT
Oncternal ..
Registre-se agora para acompanhar essas ações ao vivo no Monitor ADVFN.

O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é completamente grátis para você usar.

Faça o login em ADVFN
Registrar agora
Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte: suporte@advfn.com.br ou (11) 4950 5808.

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

P: V:br D:20230331 21:39:27